SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 19.30% growth in the revenue at Rs. 15094.20 millions for the quarter ended December 2025 as compared to Rs. 12651.90 millions during the year-ago period.The Net Profit of the company vaulted to 205.71% to Rs. 1750.80  millions from Rs. 572.70 millions in the previous quarter.The company reported a good operating profit of 3602.30 millions compared to 2134.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 15094.20 12651.90 19.30 45087.70 35669.70 26.40 52169.80 48123.90 8.41
Other Income 143.70 71.20 101.83 643.40 283.10 127.27 1004.70 474.20 111.87
PBIDT 3602.30 2134.00 68.81 11272.40 5778.10 95.09 10448.00 7973.00 31.04
Interest 314.80 480.20 -34.44 1090.50 1336.00 -18.38 1822.00 1508.20 20.81
PBDT 3287.50 1653.80 98.78 10181.90 4442.10 129.21 8626.00 6464.80 33.43
Depreciation 943.10 886.60 6.37 2834.70 2706.00 4.76 3587.90 3450.10 3.99
PBT 2344.40 767.20 205.58 7347.20 1736.10 323.20 5038.10 3014.70 67.12
TAX 593.60 194.50 205.19 1860.30 451.20 312.30 1234.20 777.70 58.70
Deferred Tax -96.70 -130.90 -26.13 -305.90 -266.50 14.78 -304.20 -101.70 199.12
PAT 1750.80 572.70 205.71 5486.90 1284.90 327.03 3803.90 2237.00 70.04
Equity 1079.70 1078.50 0.11 1079.70 1078.50 0.11 1078.50 1077.90 0.06
PBIDTM(%) 23.87 16.87 41.49 25.00 16.20 54.34 20.03 16.57 20.88

Laurus Labs Share Price

1135.00 5.40 (0.48%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×